Related Experiment Video
Updated: Apr 7, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Targeted Cancer Screening in Average-Risk Individuals
Pamela M Marcus1, Andrew N Freedman1, Muin J Khoury1
1Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
Targeted cancer screening uses risk factors to identify individuals who will benefit most. Current guidelines focus on age and smoking, but future screening may include genetics and past experiences for better outcomes.
Area of Science:
- Oncology
- Preventive Medicine
- Genetics
Background:
- Targeted cancer screening aims to optimize screening for individuals based on their specific risk factors.
- Average-risk individuals are defined as those without known inherited predispositions, significant comorbidities, or prior cancer diagnoses.
- Current research explores refining screening for average-risk populations using genetic and non-genetic factors, and past screening history.
Purpose of the Study:
- To outline the objectives of targeted cancer screening in average-risk individuals.
- To identify factors currently used for targeting cancer screening.
- To evaluate the inclusion and evidence supporting these targeting factors in major U.S. professional organization guidelines.
Main Methods:
- Review of current targeted cancer screening factors (age, smoking, race, family history, screening history).
- Analysis of inclusion of these factors in major U.S. professional screening guidelines.
- Examination of evidence supporting or refuting the use of these targeting factors, including randomized controlled trials (RCTs) and statistical modeling.
Main Results:
- Current guidelines primarily target age and smoking for lung cancer.
- Some guidelines incorporate race, family history, and previous negative screening history (e.g., cervical cancer).
- No current guidelines include common genomic polymorphisms; evidence for modestly elevated risk factors often lacks mortality benefit.
Conclusions:
- Targeted cancer screening is evolving, with future implementation likely to incorporate genetic factors and past screening experience.
- Evidence-based clinical implementation is crucial for the successful integration of new targeting strategies.
- While age and smoking show mortality benefits, other factors require more robust evidence for widespread guideline inclusion.
More Related Videos
Related Concept Videos
Cancer Prevention
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Preventive Healthcare Services
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

